Convertion predictors factors in mild cognitive impairment;Factores predictores de conversión en deterioro cognitivo leve (cohorte de seguimiento en CEMIC)

Revista Neurologica Argentina

Volumn 32, Issue 2, 2007, Pages 75-93

  Serrano, Cecilia M ^a   Taragano, F ^b   Allegri, R F ^b   Krupitzki, H ^b   Martelli, M ^b   Feldman, M ^b   Goscilo, C ^b   Tufro G ^b   Lon L ^b   Sarasola, D ^b   Dillon, C ^b   Tamaroff, L ^b  

^a CEMIC   (Argentina)

^b NONE

Author keywords

Alzheimer Disease; Dementia; MCI; Mild cognitive impairment; Risk factors

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIORAL SCIENCE; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DEMENTIA; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEMORY DISORDER; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; PATIENT EDUCATION; PREDICTOR VARIABLE; RECALL; RISK FACTOR; SYMPTOMATOLOGY;

EID: 46149097865     PISSN: 03250938     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Arizaga RL, Harris P y Allegri RF. Epidemiología de las Demencias. En "Las Demencias: Aspectos Clínicos, Neuropsicológicos y Tratamiento". JC Arango Lasprilla, S Fernández Guinea y A Ardila Editores. Editorial El Manual Moderno, México, 2003.
2. Arizaga RL. Epidemiología. En "Demencias: enfoque multidisciplinario". Mangone CA, Allegri RF, Arizaga RL, y Ollari JA Editores. Editorial Polemos, Buenos Aires, 2005.
3. Kral VC. Senescent forgetfulness: Benign and Malignant. Can Med Assoc J 1962; 86: 257-260.
4. Crook T, Bartus RT, Ferris SH, Withehouse P, Cohen GD, Gershon S. Age associated memory impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health work group. Dev Neuropsychol 1986; 2: 261-276.
5. Levy R. Ageing-associated decline. Psychogeriatrics 1994; 6: 63-68.
6. Blackford RC, La Rue A. Criteria for diagnosis AAMI: proposed improvement from the field. Dev. Neuropsychol., 1989; 5: 295-306.
7. APA; American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV, Washington, DC, 1994.
8. Visser PJ, P Scheltens and F R J Verthey. Do MCI criteria in drug trials accurately identify subjects with predementia Alzhimeir's disease? J Neurol Neurosurg Psychiatry 2005; 76: 1348-54.
9. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kolmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
10. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neuro-logy 1991; 41: 1006-1009.
11. Petersen RC. Mild cognitive impairment: transition from aging to Alzheimer's disease. In Iqbal K, Sisodia SS, Winblad B, eds. Alzheimer's disease: advances in etiology, pathogenesis and therapeutics, West Sussex, Englabnd: John Wiley & Sons, 2001: 141-151.
12. Harris P, Drake M, Allegri RF. Deterioro Cognitivo leve: en búsqueda de la predemencia. Acta Psiquiátrica y Psicológica de América Latina, 2001; 47 (1): 11-20.
13. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002; 288: 1475-83.
14. Hwang TJ, Masterman DL, Ortiz F, Fairbanks LA, Cummings JL. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord 2004; 18: 17-21.
15. Larrieu S, Letenneur L, Orgogozo J, Fabrigoule C, Amieva H, Le Carret N, Barberger-Gateau P, Dartigues JF. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 2002; 59: 1594-1599.
16. Ebly E, Hogan D, Parhad I. Cognitive impairment in the non-demented elderly. Arch Neurol, 1995; 52: 612-19.
17. Barker A, Jones R, Jennison C. A prevalence study of age-associated memory impairment. Br J Psychiatry 1995; 167: 642-648.
18. Coria F, Gomez de Caso JA, Minguez F, Rodriquez-Artalejo F, Claveria LE. Prevalence of age-associated memory impairment and dementia in a rural community. J Neurol Neurosurg Psychiatry 1993; 56: 973-976.
19. Palmer K, Fratiglioni L, Winblad B. What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment. Acta Neurol Scand Suppl 2003; 179: 14-20.
20. Folstein MF, Folstein SE, McHugh PR. "Mini mental state" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
21. Hughes CP, Berg L, Danziger WL, Coben LA and Martin RL. A new clinical scale for staging of dementia. B J Psychiatry 1982; 140: 566-572.
22. WASI (Wechsler Adult Scale - reduced) The Psychological Corporation, USA, 1999.
23. Signoret JL, Whiteley A. Memory battery scale. Intern. Neuropsych Soc Bull 1979; 2-26.
24. Allegri RF, Mangone CA, Rymberg S, Fernandez A, Taragano FE. Spanish version of the Boston naming Test in Buenos Aires. The Clinical Neuropsychologist, 1997; 11: 416-420.
25. Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968; 5: 53-60.
26. Reitan RM. Validity of the Trail Making Test as an indication of organic brain damage. Percept Mot Skills, 1958; 8: 271.
27. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist 1969; 9: 179-186.
28. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314.
29. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 53-63.
30. Mc Khann G, Drachman D, Folstein M, Katzman R, Price D and Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944.
31. Asociación Médica Mundial. Declaración de Helsinski. Principios éticos para las investigaciones médicas en seres humanos. Rev Neurol Arg 2001; 26: 75-77.
32. Kleinbaum DG. Statistics in the health sciences: Survival analysis. New York: Springer-Verlag; 1996.
33. Dawsonn-Saunders B, Trapp R. Basic & Clinical Biostatistics. Appletonn & Lange eds. Second edition. 1994.
34. Serrano CM y Allegri RF. Tratamiento Farmacológico de las Demencias.En El abordaje Farmacológico en el Paciente Psiquiátrico Adulto. Wikinski S y Jufre G. Editorial Paramericana, Buenos Aires, 2005.
35. Gao S, Hendrie HC, Hall KS, and Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer's disease. A meta-analysis. Arch Gen Psychiatry 1998; 55: 809-815.
36. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB.. Progression to dementia in patients with isolated memory loss. Lancet 1997; 349: 763-765.
37. Tierney MC, Szalai JP, Snow WG Fisher RH, Nores A, Nadon G, et al. Prediction of probable Alzheimer's disease in memory impaired patients: a prospective longitudinal study. Neurololgy 1996; 46: 661-665.
38. Daly E, Zaitchck D, Copeland M Schmahmann J, Gunther J, Albert M. Predicting conversion to Alzheimer's disease using standardized clinical information. Arch Neurol 2000; 57: 675-680.
39. Devanand DP, Folz M, Gorlyn M Moeller JR, Stern Y. Questionable dementia: clinical course and predictor outcome. JAGS 1997; 45: 321-328.
40. Perneczky R, Pohl C, Sorg C, Hartmann J, Tosic N, Grimmer T, Heitele S, Kurz A. Impairment of activities of daily living requiring memory or complex reasoning as part of the MCI syndrome. Int J Geriatr Psychiatry 2006; 21: 158-62.
41. Taragano FE, Allegri RF, Vicario A, Bagnati P, Pereyra Redondo JC, Kremer J, et al. Arterias, Corazón y Cerebro: Fisiopatología Vascular de los trastornos neuropsiquiátricos (2da Edición). Ediciones Ediser, Buenos Aires, 2005.
42. Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 2001; 56: 1683-9.
43. Petersen RC, Thomas RG, Grundman M Bennett D, Doody R, Ferris S, and Alzheimer's Disease Cooperative Study Group. Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment. N Engl J Med 2005; 352: 2378-2388.
44. Katzman R. Education and the prevalence of dementia an Alzheimer's disease. Neurology 1993; 43: 13-20.
45. Harris P, Drake M, Allegri RF. Deterioro Cognitivo leve: en búsqueda de la predemencia. Acta Psiquiátrica y Psicológica de América Latina 2001; 47: 11-20.
46. Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, et al. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol 2005; 62: 1601-1608.